Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7297 p531
1 May 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Concerns raised as new pharmacy course launched

Will students’ education suffer?

Kingston University received approval for its MPharm degree course from the Royal Pharmaceutical Society this week. However, the Society expressed concerns over how new school openings might impact on pharmacy education.

Kingston is currently recruiting students and the first undergraduates will start their courses in September. It plans to take 45 students, although there has been a large demand for places and it has made offers to about 200 applicants.

John Brown, professor of pharmacy and head of the new department at Kingston, told The Journal that the course will be run in conjunction with the medical school at St George’s Hospital, Tooting, London. “Each year a whole module will be taught at St George’s Hospital Medical School. Clinical pharmacy will be partly taught by clinicians at St George’s,” he said.

According to Professor Brown, the new course is expected to recruit pharmacy students over and above those at existing schools of pharmacy in London and the south-east of England.

Kingston is one of an increasing number of universities looking to provide pharmacy degree courses. Three universities are currently seeking approval, three more are about to start this process and at least another six have expressed an interest. Robert Dewdney, head of education, Royal Pharmaceutical Society, told The Journal: “I am deeply concerned at the strain on the limited pool of pharmacy academics, the resources and goodwill of the NHS towards undergraduate clinical teaching and preregistration training places.”

Although Dr Dewdney believes that some of the proposals and ideas from universities newly involved in pharmacy undergraduate teaching are admirable and their commitments to achieving good outcomes in terms of the qualities of graduates are genuine, he is worried that the quality of provision in existing as well as proposed schools is at risk. “What is needed is a national plan for the expansion, and eventual consolidation, of pharmacy education,” he said. “The Society, as regulator, is not in a position to do this on its own and Government policies in health and education leave Department of Health and Higher Education Funding Council officials in the awkward position of not knowing if, or how, to intervene.”

The University of Hertfordshire is one of the universities that has expressed an interest in establishing a new school of pharmacy. It hopes to accept its first intake of students in September 2005, providing it can satisfy the requirements of the Society. Mike Pittilo, pro vice-chancellor at the university, told The Journal that Bedfordshire and Hertfordshire have the highest vacancy rates for pharmacists in the NHS across England. “Consequently, there is enthusiasm for this development from our local pharmacy colleagues,” he said.

The university has advertised for a foundation professor in pharmacy. “We would be looking at the new head of pharmacy to come with some innovative ideas,” Professor Pittilo said. One area that the university is interested in is interprofessional learning. “We are keen to explore to what extent the education and training can be enriched by training alongside other health professionals,” he added.

Leading article p530

Back to Top


©The Pharmaceutical Journal